Cargando…
Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population
SUMMARY: Our aim was to evaluate the gap in osteoporosis treatment and the impact of osteoporosis treatment on subsequent fragility fractures. We found osteoporosis medication use lowered risk of subsequent fractures by 21% and that black race, higher CCI scores, dementia, and kidney diseases reduce...
Autores principales: | Keshishian, A., Boytsov, N., Burge, R., Krohn, K., Lombard, L., Zhang, X., Xie, L., Baser, O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524851/ https://www.ncbi.nlm.nih.gov/pubmed/28536737 http://dx.doi.org/10.1007/s00198-017-4072-6 |
Ejemplares similares
-
Interstate Variation in the Burden of Fragility Fractures
por: King, Alison B, et al.
Publicado: (2009) -
Post-fracture care programs for prevention of subsequent fragility fractures: a literature assessment of current trends
por: Åkesson, K.E., et al.
Publicado: (2022) -
Economic Burden of Osteoporosis-Related Fractures in the US Medicare Population
por: Williams, Setareh A., et al.
Publicado: (2020) -
Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States
por: Burge, R. T., et al.
Publicado: (2016) -
Are we closing the gaps in the management of osteoporosis following fragility fractures of the femur?
por: Sadat-Ali, Mir, et al.
Publicado: (2019)